UHS Upgrades 2025 EPS Forecast to $20.50 on DPP Gains and Behavioral Health Growth

Key Highlights from Universal Health Services' Q2 2025 Earnings Call

Universal Health Services (UHS) provided an updated outlook for its 2025 earnings during its recent earnings call. The company raised its midpoint for full-year earnings per diluted share (EPS) by 7%, now projecting $20.50 compared to the previous guidance of $19.20. This increase is primarily attributed to higher reimbursements under the Direct Pay Program (DPP). However, the revised guidance does not factor in potential Medicaid supplemental programs in Washington, D.C., or other pending approvals.

Marc D. Miller, CEO of UHS, highlighted the strong performance of West Henderson Hospital, which generated positive EBITDA in the second quarter. He also acknowledged challenges at Cedar Hill Regional Medical Center, noting that delays in hospital certification and other start-up issues were more difficult than expected. Despite these hurdles, demand for emergency services has remained robust.

UHS also shared details about new behavioral health facilities, including a 96-bed hospital in Grand Rapids, Michigan, and a 41-bed treatment center in South Carolina. Additionally, the company is developing a 144-bed behavioral health hospital in Bethlehem, Pennsylvania, and a 120-bed facility in Independence, Missouri, both scheduled to open in late 2026.

Financial Performance and Outlook

Steve G. Filton, CFO of UHS, reported net income attributable to UHS per diluted share of $5.43 for the second quarter of 2025. After adjusting for various factors, the adjusted net income was $5.35 per share. On a same-facility basis, acute care hospital admissions increased by 2.0% year-over-year, while net revenues rose by 5.7%.

In the behavioral health segment, same-facility net revenues grew by 5.4%, driven by a 4.2% increase in revenue per adjusted day and a 1.2% rise in adjusted patient days. However, cash generated from operating activities for the first half of 2025 decreased by $167 million to $909 million compared to the same period in 2024. Capital expenditures for the first half totaled $505 million, with $332 million used for share repurchases.

Looking ahead, UHS expects to collect $58 million in Tennessee directed payment program receivables in the third quarter. However, the company warned that starting in 2028, the aggregate net benefit will be reduced annually by approximately $360 million to $400 million by 2032 due to new Medicaid legislation. Management emphasized that the final impact remains uncertain.

Analyst Questions and Strategic Adjustments

During the Q&A session, analysts raised concerns about the projected $360 million to $400 million annual impact from Medicaid changes. Filton noted that the company is exploring strategic shifts in behavioral program structures, cost-cutting measures, and new DPP initiatives as potential solutions. Miller added that while the impact is anticipated, there may be adjustments made over time.

Other questions focused on Cedar Hill Regional Medical Center's $25 million start-up loss and future expectations. Filton clarified that another $25 million drag is already factored into the guidance for the back half of the year. He also mentioned that the facility is expected to see a ramp-up once it receives certification.

Analysts also asked about the path to expanding outpatient behavioral services. Filton outlined plans to open 10 to 15 new outpatient facilities annually and improve patient retention through step-down programs. Regarding pricing and volume growth, Filton noted that excluding the Tennessee impact, revenues increased by 5.4%, split between a 4.2% increase in pricing and a 1.2% rise in adjusted patient days.

Sentiment and Strategic Focus

Analysts maintained a neutral to slightly negative tone, focusing on headwinds such as Medicaid legislation, behavioral health volume challenges, and Cedar Hill losses. Management’s response was confident in prepared remarks but became more defensive and cautious during questioning, particularly regarding future Medicaid changes and behavioral health volumes.

Compared to the previous quarter, management’s tone shifted from confident and optimistic to more defensive and focused on contingency planning. While Q1 emphasized expense controls and recovering volumes, Q2 centered on strategic flexibility and scenario planning.

Risks and Concerns

Key risks include significant reductions in Medicaid supplemental payments starting in 2028, with an estimated $360 million to $400 million annual impact by 2032. Cedar Hill Regional Medical Center contributed a $25 million loss in the quarter, with another $25 million expected in the back half of the year. Persistent labor shortages in certain markets, particularly for behavioral health therapists and technicians, remain a challenge.

Cash flow from operations declined year-over-year, attributed to timing of Medicaid payments and increased receivables. Analysts are concerned about sustaining behavioral health volume and margin growth, as well as the impact of new Medicaid legislation and payer mix shifts.

Final Takeaway

Universal Health Services entered the second half of 2025 with higher full-year EPS guidance, driven by improved DPP reimbursement and continued acute care revenue growth. Behavioral health expansion, especially in outpatient services, remains a key focus. However, regulatory and operational headwinds—including future Medicaid payment changes and start-up losses at new facilities—require ongoing strategic flexibility and cost controls. Management expressed confidence in adapting to these challenges, emphasizing proactive planning and new growth initiatives as the company navigates a changing healthcare landscape.